Better Than Botox? New Anti-Wrinkle Drug Launching Newsmax Health J&J expects to seek U.S. approval next year for an anti-wrinkle drug that could break Botox's near monopoly, an 85 percent market share. The J&J product could be available in the United States in 2015 and overseas a few years later, the company said. |
No comments:
Post a Comment